Assessing the relative efficacy of different agents based on the outcomes from meta-analyses
2008

Concerns About Meta-Analysis of Osteoporosis Treatments

publication Evidence: low

Author Information

Author(s): Boonen S, Vanderschueren D, Haentjens P

Primary Institution: Bone Research Unit, Leuven University Department of Experimental Medicine, Katholike Universiteit Leuven

Conclusion

The meta-analysis has major limitations and its conclusions may be misleading due to inconsistent trial selection and statistical methods.

Supporting Evidence

  • The authors question the validity of the meta-analysis due to inconsistent inclusion criteria.
  • Different statistical methods were used for different therapies without clear justification.
  • The treatment effect of risedronate was likely underestimated due to inclusion of non-osteoporotic patients.

Takeaway

The study questions the reliability of a meta-analysis comparing osteoporosis treatments, suggesting it may not have been done properly.

Potential Biases

Potential bias due to subjective decisions in trial inclusion/exclusion and statistical methods.

Limitations

Inconsistent trial selection criteria and different statistical methods used for different therapies.

Digital Object Identifier (DOI)

10.1111/j.1742-1241.2007.01594.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication